Electrophysiology News and Research

RSS

Boston Scientific in bid to take over Cameron Health

Boston Scientific, the second-biggest cardiac-device maker, will pay $150 million when the deal closes and another $150 million if Cameron’s technology called the S-ICD System wins U.S. Food and Drug Administration approval, the Natick, Massachusetts-based company said in a statement yesterday.

12 Mar 2012

Boston Scientific exercises option to acquire Cameron Health

Boston Scientific Corporation announces the exercise of its option to acquire Cameron Health, Inc., a privately held company based in San Clemente, California.

9 Mar 2012

New minimally invasive procedure can treat resistant hypertension

A radically different approach to treating high blood pressure - using a minimally invasive procedure- is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.

8 Mar 2012

Stereotaxis fourth quarter net loss increases to $5.5M

Stereotaxis, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

6 Mar 2012

Adolescents more sensitive to effects of sport-related concussions

Research results published in Brain Injury by Universit- de Montr-al neuropsychologist Dave Ellemberg reveal that adolescents are more sensitive to the effects of a sport-related concussion than adults or children.

28 Feb 2012

International effort to define ECG interpretation standards in athletes

On Feb. 13-14, the American Medical Society for Sports Medicine (AMSSM) partnered with the ESC Sports Cardiology Section, the PACES, other leading U.S. cardiologists, BJSM, and F-MARC in an effort to define ECG interpretation standards in athletes and develop a comprehensive online training module for physicians around the world to gain expertise in ECG interpretation and the proper evaluation of ECG abnormalities suggestive of a pathologic cardiovascular disorder.

22 Feb 2012

First use of HeartLight Endoscopic Ablation System to treat atrial fibrillation

For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected by atrial fibrillation (AFib), one of the nation's most common heart ailments.

22 Feb 2012

UC San Diego offers catheter ablation for patients with atrial fibrillation

UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia.

17 Feb 2012

Study: Syncope results in unexplained cardiac arrests

Up to 45,000 sudden cardiac arrests occur each year in Canada, and less than five percent survive. In some of these cases, the event cannot be explained by the presence of underlying heart disease. In order to identify people at risk of these unexplained cardiac events, a newly published study examined the presence of certain warning symptoms that are present in people who have been resuscitated from a cardiac arrest.

10 Feb 2012

Fogarty Institute's Advanced Endovascular Training Fellowship to begin on July 1

The Fogarty Institute for Innovation announced today that it has launched its Advanced Endovascular Training Fellowship. This unique, year-long clinical training program for postgraduate physicians, which begins July 1, 2012, will provide Fellows with broad exposure to all aspects of endovascular patient care, with an emphasis on interventional training.

7 Feb 2012

Marin Magazine names Sutter Health physicians among [415] Top Doctors 2012

Almost 250 physicians at California Pacific Medical Center, Sutter Pacific Medical Foundation, and Novato Community Hospital - all part of the Sutter Health network - have been named on the prestigious list of [415] Top Doctors 2012 by Marin Magazine.

3 Feb 2012

International conference focuses on where and how memory is formed

The University of Haifa is hosting an international conference of leading brain researchers from around the world next week, where the participants will be attempting to answer the question of where and how memory is stored; or in less ordinary terms: "Cell and molecular mechanisms of memory formation".

3 Feb 2012

FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds

Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms.

From Medtronic 30 Jan 2012

Sorin opens ACCESS training center in Clamart

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today the opening of its Advanced Center for Continuous Education on Scientific Solutions - ACCESS - training center in Clamart.

27 Jan 2012

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.

24 Jan 2012

Risk of sudden cardiac arrest while running a marathon is low in the healthy: Study

There have been reports of a marathoner collapsing suddenly with no pulse. Now a large study finds such calamities are rare and usually due to a pre-existing heart problem. The study also found such incidents are increasing as more runners try to go the distance.

12 Jan 2012

Stereotaxis completes 50 clinical procedures with new Niobe ES system to treat cardiac arrhythmias

Stereotaxis, Inc. today announced the completion of the first 50 clinical procedures using the Company's new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia.

11 Jan 2012